Another study showed that ginsenoside Rg1 also alleviated this phenotype and reduced NLRP3, IL-1β, and cleaved IL-1β expression in NASH model mice by inhibiting inflammasome activation (Xu B. et al., 2018). The gene discussed is NLRP3; the disease is metabolic dysfunction-associated steatohepatitis.